Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Allakos Inc (ALLK)

Allakos Inc (ALLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share GlobeNewswire - Wed Apr 2, 2025

ALLK : 0.3291 (-0.06%)
Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results GlobeNewswire - Wed Mar 12, 2025

ALLK : 0.3291 (-0.06%)
Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade Stocktwits - Mon Jan 27, 2025

The disappointing results prompted Allakos to terminate AK006-related programs across all functions and implement a 75% workforce reduction.

ALLK : 0.3291 (-0.06%)
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring GlobeNewswire - Mon Jan 27, 2025

ALLK : 0.3291 (-0.06%)
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Wed Nov 6, 2024

ALLK : 0.3291 (-0.06%)
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers GlobeNewswire - Thu Oct 10, 2024

ALLK : 0.3291 (-0.06%)
Why Shares of Allakos Are Up Wednesday Motley Fool - Wed Sep 27, 2023

The stock is bouncing back from a recent 52-week low.

ALLK : 0.3291 (-0.06%)
Why Allakos Stock Skyrocketed Nearly 9% Higher Today Motley Fool - Fri May 12, 2023

The company is poised to report a critical set of clinical data in the coming months.

ALLK : 0.3291 (-0.06%)
Why Allakos Stock Was Heating Up Today Motley Fool - Tue Mar 7, 2023

A notable analyst upgrade had investors piling into this clinical-stage biotech stock today.

ALLK : 0.3291 (-0.06%)
PIPR : 373.30 (+1.53%)
Why Allakos Stock Is on Fire Today Motley Fool - Wed Aug 31, 2022

Investors appear to be getting into position ahead of a major upcoming catalyst.

ALLK : 0.3291 (-0.06%)

Barchart Exclusives

As Taiwan Semi Hikes Its Dividend 20%, Should You Buy TSM Stock? Barchart - Wed Jan 21, 6:30PM CST
Taiwan Semiconductor continues to increase its payout. Is the growth sustainable? Here's what to know. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot